Cite
Evaluation of Information in Summaries of Product Characteristics (SmPCs) on the Use of a Medicine in Patients With Hepatic Impairment
MLA
Rianne A. Weersink, et al. “Evaluation of Information in Summaries of Product Characteristics (SmPCs) on the Use of a Medicine in Patients With Hepatic Impairment.” Frontiers in Pharmacology, vol. 10, Jan. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ac850c7c096c4f3dc5fbce97ee966d0c&authtype=sso&custid=ns315887.
APA
Rianne A. Weersink, Lotte Timmermans, Margje H. Monster-Simons, Peter G. M. Mol, Herold J. Metselaar, Sander D. Borgsteede, & Katja Taxis. (2019). Evaluation of Information in Summaries of Product Characteristics (SmPCs) on the Use of a Medicine in Patients With Hepatic Impairment. Frontiers in Pharmacology, 10.
Chicago
Rianne A. Weersink, Lotte Timmermans, Margje H. Monster-Simons, Peter G. M. Mol, Herold J. Metselaar, Sander D. Borgsteede, and Katja Taxis. 2019. “Evaluation of Information in Summaries of Product Characteristics (SmPCs) on the Use of a Medicine in Patients With Hepatic Impairment.” Frontiers in Pharmacology 10 (January). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ac850c7c096c4f3dc5fbce97ee966d0c&authtype=sso&custid=ns315887.